Editorial · 28 Feb 2025
Conference abstractPublished 26 Jun 2013
Molecular mechansisms of hyperoxic lung injury: Implications for ronchopulmonary dysplasia (BPD) and ARDS
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hyperoxia is routinely used in the treatment of pulmonary insufficiency and respiratory distress in preterm and term infants and in adults with acute respiratory disease (ARDS). However, in infants, hyperoxia contributes to the development of chronic lung disease (CLD), which is termed bronchopulmonary dysplasia (BPD). The molecular mechanisms of oxygen-mediated lung injury are not understood, but reactive oxygen species (ROS) are the most likely candidates. ROSare also responsible for many other lung diseases such as acute respiratory distress syndrome (ARDS), asthma, emphysema, chronic obstructive pulmonary disease (COPD), and lung cancer. Results from our laboratory demonstrate a novel role for cytochrome P450 (CYP)1A enzymes in the detoxification of ROS-mediated lipid peroxidation products, e.g., F2-isoprostanes. Our major observations are that mice lacking the genes for CYP1A1 or 1A2 are more susceptible to hyperoxic lung injury than wild type mice, with Cyp1a2-null mice being the most sensitive. On the other hand, mice lacking the gene for CYP1B1, are less susceptible to lung injury, suggesting a pro-oxidant role for CYP1B1. Mice pre-treated with the CYP1A inducer (β-napthoflavone (BNF), followed by exposure to hyperoxia leads to protection against lung injury. We also found formation of bulky oxidative lesions (oxidative DNA adducts) in tracheal aspirates of premature infants and adults who received supplemental oxygen, and this was associated with BPD and ARDS, thereby suggesting that these adducts could serve as novel biomarkers of these diseases. Future studies could lead to the development of rational strategies for the prevention/treatment of lung diseases associated with hyperoxia.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 30 Dec 2024
ARDS and Acute Lung Injury: Pathophysiology and Key Differences
Research article · 5 Dec 2024
Evaluate the Efficacy and Safety of Lucinactant in Preventing Bronchopulmonary Dysplasia (BPD) in Premature Infants
Article · 28 Nov 2023
A Significant Risk in Neonatal Health: Prematurity and Bronchopulmonary Dysplasia (BPD)
Research article · 15 Jun 2023
Ureaplasma, Azithromycin, and Varying Definitions of BPD (Bronchopulmonary Dysplasia) in Preterm Infants: Challenges for Clinical Care and Drug Development
More from this journal
The newest in Journal of Biotechnology & Biomaterials.
Editorial · 30 May 2025
Biocatalytic Conversion of Agricultural Waste into Value-Added Chemicals Using Engineered Microbial Systems
Editorial · 30 May 2025
3D Bioprinting of Vascularized Tissue Constructs Using Bioink-Embedded Endothelial Cells
Editorial · 30 May 2025
Development of Flexible Bioelectronic Interfaces for Real-Time Neural Signal Monitoring
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Bhagavatula Moorthy”
